Skip to content

The value of pepsin in saliva for diagnosis of gastroesophageal reflux disease

The value of pepsin in saliva for diagnosis of gastroesophageal reflux disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018548
Enrollment
Unknown
Registered
2018-09-23
Start date
2018-10-01
Completion date
Unknown
Last updated
2018-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal Reflux Disease

Interventions

Gold Standard:gastroscope
24 hour PH-impedance monitoring
Index test:pepsin in saliva

Sponsors

the Second Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Completed gastroscope, with or without GERD symptoms: heartburn,regurgitation or GerdQ=8, and(or)with chronic cough, asthma, pharyngolaryngitis, tympanitis, nasosinusitis, glous hystericus and so on.

Exclusion criteria

Exclusion criteria: 1. With Zollinger-Ellison syndrome;Esophageal achalasia; Esophageal spasm; Esophagostenosis and other esophagus disease or esophageal surgery; 2. With a history of chronic disease,such as asthma or neurological disease; 3. With a history of malignancy; 4. Can not complete the study for any reason, such as language comprehension disorders, mental illness or can not tolerate the test; 5. With history of taking antiacid drugs or prokinetic agent a week before the test; 6. With anxiety symptoms(HAMA>14); 7. With a history of taking the medicine to relieve anxiety symptom,insomnias recently; 8. Under 18 years old; 9. In pregnancy and lactation.

Design outcomes

Primary

MeasureTime frame
24h PH-impedance monitoring;pepsin in saliva;gastroscope;

Countries

China

Contacts

Public ContactXin He

Chongqing Medical University

hexinying10032@outlook.com+86 18523577216

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026